… the sector, but lately merger-and-acquisition activity has been anemic. …
Shares of Pfizer rose as much as 2.6% on Tuesday before … the flip side of the M&A equation, biotech stocks … its dwindling options.
Even as biotech companies become more affordable …
VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
